Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Subros Ltd. Earnings Release 2026

May 19, 2026

60906_rns_2026-05-19_e973d030-1f17-4c10-a505-ff40c415a8da.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Subres

SL/BSE/NSE/2026-27

May19, 2026

The Manager,
Listing Department,
National Stock Exchange of India Ltd.,
'Exchange Plaza' C-1, Block G,
Bandra-Kurla Complex, Bandra (E),
Mumbai-400 051.
Security ID: SUBROS

Dy. General Manager,
Department of Corporate Services,
BSE LIMITED,
First Floor, P.J. Towers,
Dalal Street, Fort,
Mumbai – 400001.
Security ID: 517168

Dear Sir/Madam,

Sub: Submission of Publication of Financial Results in Newspaper(s)

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the newspaper publication of the audited financial results for the year ended on 31st March, 2026 approved by the Board of Directors in its meeting held on 18th May, 2026 published in Financial Express and Jansatta on 19th May, 2026.

We request you to kindly take the same on record.

Thanking you,

Yours faithfully,
For SUBROS LIMITED

KAMAL SAMTANI
Digitally signed by KAMAL SAMTANI
Date: 2026.05.18
23:40:32 +05'30'

Kamal Samtani
Company Secretary

SUBROS LIMITED

Corporate & Registered Office: LGF, World Trade Centre, Barakhamba Lane, New Delhi 110001 (India). Tel: 23414946-49 | Fax:01123414945 Website: www.subros.com | CIN: L74899DL1985PLC020134.


WWW.FINANCIALEXPRESS.COM

TUESDAY, MAY 19, 2026

FINANCIAL EXPRESS

11

"IMPORTANT"

Whilst care is taken prior to acceptance of advertising copy, it is not possible to verify its contents. The Indian Express (P) Limited cannot be held responsible for such contents, nor for any loss or damage incurred as a result of transactions with companies, associations or individuals advertising in its newspapers or Publications. We therefore recommend that readers make necessary inquiries before sending any monies or entering into any agreements with advertisers or otherwise acting on an advertisement in any manner whatsoever.

NELCAST

LIMITED

CITY: LONDON, W1 3D, UK. Tel: 0144 84444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444

STATEMENT OF AUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31ST MARCH 2026

No. Particulars Discrepancy* Consolidated
1 Month Ended 2-3 Months Ended 1 Month Ended 2-3 Months Ended
31/04/2025 31/11/2025 31/04/2025 31/11/2025 31/04/2025 31/11/2025 31/04/2025 31/11/2025
1 Total income from Operations 2,0117.54 2,0278.27 2,4436.27 2,6207.32 1,8943.54 2,117.91 2,0278.27 2,4436.27
2 % of Total Income from Sales 1,142.78 1,170.82 1,297.08 1,376.82 1,268.78 1,297.08 1,268.78 1,376.82
3 Net Profit/Loss for the period before tax 1,088.66 1,078.28 1,018.28 999.27 1,003.07 999.27 1,003.07 999.27
4 Net Profit/Loss for the period after tax 1,088.66 1,078.28 1,018.28 999.27 1,003.07 999.27 1,003.07 999.27
5 Net Profit/Loss for the period after tax 1,088.66 1,078.28 1,018.28 999.27 1,003.07 999.27 1,003.07 999.27
6 Other Profit/Loss for the period after tax 1,088.66 1,078.28 1,018.28 999.27 1,003.07 999.27 1,003.07 999.27
7 Other Costs/Amounts Income for the period 1,512.08 1,556.80 1,578.81 1,669.69 1,578.05 1,512.08 1,556.80 1,578.81
8 Economy/Price Capital 1,184.00 1,190.02 1,190.02 1,190.02 1,190.02 1,190.02 1,190.02 1,190.02
9 Share in the Authorized balance (Fixed) 5,750.69 5,504.69 5,750.69
10 Earnings in the year of the 31st 5,750.69 5,504.69 5,750.69
11 2019 to the Question as not annualised
12 Share 1.76 1.83 1.85 3.31 4.26 1.76 1.83 1.85
13 1.76 1.83 1.85 3.31 4.26 1.76 1.83 1.85 3.31

Notes:
The effect is an extract of the detailed form of a different document which is sent to the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, and the Department of Finance.

SUBROS LIMITED

REGD. OFFICE: LGP, WORLD TRADE CENTRE, BARANHAMRA LINK, NEW DELHI-110001

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

S1 No. Particulars 1st Quarter 2nd Quarter
QUARTER ENDED 31/04/2025 YEAR ENDED 31/04/2025 QUARTER ENDED 31/04/2025 YEAR ENDED 31/04/2025
31.05.2025 31.11.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025
EXPRESS OF STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026

img-0.jpeg

S1 No. Particulars December 31 December 31
QUARTER ENDED 31/04/2025 YEAR ENDED 31/04/2025 QUARTER ENDED 31/04/2025 YEAR ENDED 31/04/2025
31.05.2025 31.11.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025 31.05.2025
1 Total Income from Operations 1,162.78 1,170.82 1,297.08 1,376.82 1,268.78 1,297.08 1,268.78 1,376.82
2 Net Profit/Loss for the period before Tax 4,886 4,875 5,105 22,631 20,446 4,632 4,409 5,161
3 Net Profit/Loss for the period after Tax 4,886 4,875 5,105 22,631 20,446 4,632 4,409 5,161
4 Net Profit/Loss for the period after tax 4,886 4,875 5,105 22,631 20,446 4,632 4,409 5,161
5 Other Costs/Amounts Income for the period 1,088 1,078 1,297 1,376 1,268 1,297 1,268 1,376
6 Operating Profit/Loss for the period 1,088 1,078 1,297 1,376 1,268 1,297 1,268 1,376
7 Operating Profit/Loss for the period 1,088 1,078 1,297 1,376 1,268 1,297 1,268 1,376

Notes:

  1. The above is an extract of the detailed form of a printed and year ended (distribution and consolidation) financial results filed with the Stock Exchange under Regulation 32 of SEER (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the quarter and year ended (distribution and consolidation) financial results are available on website of the Stock Exchange(s) www.twendia.com and www.twendia.com and the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance, the Department of Finance,

26

जून 2024

रोग संरक्षित चाइल्ड लिमिटेड

रोग का कारण 1. 15 से 20 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है। 2. 20 से 30 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है। 3. 30 से 40 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है। 4. 40 से 50 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

1. 15 से 20 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

2. 20 से 30 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

1. 15 से 20 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

2. 20 से 30 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

3. 30 से 40 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

4. 40 से 50 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

5. 30 से 40 मिनट तक चलने पर 5 दिन से 15 घंटे तक का रोग हो सकता है।

3. 30 से 40 मिनट तक चलने पर 5 दिन से 15 घंटे

4. 30 से 40 मिनट तक चलने पर 5 दिन से 15

5. 30 से 40 मिनट तक चलने पर 5 दिन से 15

6. 30 से 40 मिनट तक चलने पर 5 दिन से 15

7. 30 से 40 मिनट तक चलने पर 5 दिन से 15

8. 30 से 40 मिनट तक चलने पर 5 दिन से 15

9. 30 से 40 मिनट तक

4. रोग

5. 30 से 40 मिनट तक

6. 30 से 40 मिनट तक

5. रोग

6. 30 से 40 मिनट तक

6. 30 से 40 मिनट तक

7. रोग

8. 30 से 40 मिनट

8

1

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305